Showing results (151-160 of 640) with videos related to
Sort By:
Pageof 64
Cancer|January 1, 1988
Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scanM S Soloway, S W Hardeman, D Hickey, et al.Urological Research|January 1, 1988
The effect of high energy shock waves (HESW) on human bone marrowC Yang, W D Heston, S Gulati, et al.Urology|February 5, 1999
Clinical significance of small (less than 0.2 cm3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels less than 10 ng/mLN E Fleshner, M O'Sullivan, C Premdass, et al.Surgical Oncology Clinics of North America|April 1, 1995
Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practiceG Dalbagni, C Cordon-Cardo, V Reuter, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 1988
Case report of hepatotoxicity associated with maprotilineR P Weinstein, J Y GosselinThe Prostate|June 1, 1994
An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancerJ Vieweg, W D Heston, E Gilboa, et al.The Prostate|September 19, 1997
Prostatic tumor implantation in the nude mouse via a perineal approachM Garzotto, R Huryk, W R Fair, et al.British Journal of Urology|March 1, 1996
Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial resultsF Abbas, M Kaplan, M S SolowayCancer Research|March 1, 1984
Differential effect of alpha-difluoromethylornithine on the in vivo uptake of 14C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumorW D Heston, D Kadmon, D F Covey, et al.Urological Research|January 1, 1987
Aromatization of androstenedione to estrogen by benign prostatic hyperplasia, prostate cancer and expressed prostatic secretionsN N Stone, V P Laudone, W R Fair, et al.Pageof 64